3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
110
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
6
Neoplasms
4
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Infertility
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Cancer Female
2
Sleep Wake Disorders
1
Quality of Life
1
Pulmonary Fibrosis
1
Prostatic Neoplasms
1
Primary Breast Cancer
1
Polycystic Ovary Syndrome
1
Paget's Disease, Mammary
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Recurrence, Local
1
Liver Neoplasms
1
Hot Flashes
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Breast Cancer Subjects
1
Interventions
Letrozole
5
Clomiphene
4
follitropin alfa
2
Tamoxifen
2
Metformin
2
Goserelin
2
Cyclophosphamide
2
follitropin beta
1
cetrorelix
1
Urofollitropin
1
Triptorelin Pamoate
1
Thioctic Acid
1
Therapeutics
1
Surgical Procedures, Operative
1
Sperm Injections, Intracytoplasmic
1
Neoadjuvant Therapy
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Infertility
×
Tamoxifen
×
Clear all
NCT03011684
2026-06-04
TALES
University of California, San Francisco
Phase 3
Recruiting
309 enrolled
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled